Related Experiment Video
Updated: May 24, 2026

Drug-Induced Sleep Endoscopy (DISE) with Target Controlled Infusion (TCI) and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Emerging therapies for obstructive sleep apnea
Morohunfolu Akinnusi1, Ranime Saliba, Ali A El-Solh
1The Veterans Affairs Western New York Healthcare System, Buffalo, NY 14215-1199, USA.
Abstract:
Obstructive sleep apnea (OSA) is a prevalent disorder often associated with daytime sleepiness, cognitive dysfunction, and adverse cardiovascular consequences. Available therapies are limited by either lack of long-term adherence or low response rates. Two emerging therapies hold promise in providing alternatives to patients with OSA. The first stems from the importance of the upper-airway dilator muscles in maintaining pharyngeal stability. Electrical stimulation of the genioglossus muscle improves both upper-airway diameter and ameliorates pharyngeal obstruction. The results of phase I and II clinical trials hold promise, but the reported improvements in the apnea-hypopnea index vary between subjects and concerns about long-term safety await long-term studies. The second technology relies on creating an increased expiratory nasal resistance via a bidirectional valve designed to be worn just inside the nostrils. Initial findings of clinical trials suggest reduction in severity of sleep apnea and subjective daytime sleepiness. Considerable heterogeneity in response to the nasal device was noted despite the high adherence rates. It remains unclear which patients will likely benefit a priori from these devices.
Insights
New therapies for obstructive sleep apnea (OSA) show promise. Electrical stimulation and nasal resistance devices may offer alternatives, but patient response varies, requiring further study.
Area of Science:
- Sleep Medicine
- Otolaryngology
- Neuromodulation
Background:
- Obstructive sleep apnea (OSA) is a common condition linked to serious health issues like cardiovascular disease and cognitive impairment.
- Current OSA treatments face challenges with patient adherence and effectiveness.
- Novel therapeutic approaches are needed to improve patient outcomes.
Purpose of the Study:
- To review emerging treatments for obstructive sleep apnea (OSA).
- To evaluate the potential of genioglossus muscle electrical stimulation and nasal expiratory resistance devices.
- To discuss the efficacy and limitations of these new OSA therapies.
Main Methods:
- Review of phase I and II clinical trial data for two novel OSA therapies.
- Assessment of upper-airway stimulation via genioglossus muscle electrical stimulation.
- Evaluation of a nasal device designed to increase expiratory nasal resistance.
Main Results:
- Electrical stimulation of the genioglossus muscle showed potential in improving upper-airway diameter and reducing pharyngeal obstruction, with variable apnea-hypopnea index improvements.
- The nasal expiratory resistance device demonstrated reductions in sleep apnea severity and daytime sleepiness, despite noted heterogeneity in patient response.
- High adherence rates were observed for the nasal device, but long-term safety data for both methods are pending.
Conclusions:
- Emerging therapies like genioglossus muscle electrical stimulation and nasal expiratory resistance devices offer potential new avenues for OSA management.
- Significant variability in individual patient response to these novel treatments was observed.
- Further research is necessary to determine long-term safety, efficacy, and patient selection criteria for these promising OSA interventions.
More Related Videos
05:34Auricular Acupuncture as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Sleep Disorders
Published on: August 18, 2023
04:53Acupoint Application Combined with Ear Plaster Therapy for Treating Sleep Disorders with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Published on: October 18, 2024
Related Concept Videos
Sleep Apnea
The condition is more prevalent among...
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation (NIPPV)
Cardiopulmonary Resuscitation V: Advanced Airway Management Techniques
Cardiopulmonary Resuscitation II: ACLS Airway Management
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation